Oct 3, 2004 | NEWS
October 3, 2004 October 3, 2004 – In a paper published today in the online edition of Nature Genetics, a deCODE-led team of scientists present the results of a large-scale population study linking recombination rate with maternal age and fertility. In the paper,...
Jun 18, 2004 | NEWS
Study to conclude in late August; data will be used in the design of an information-rich Phase III study for the prevention of heart attack Reykjavik, ICELAND, June 18, 2004 ― deCODE genetics (Nasdaq:DCGN) today announced the completion of enrollment for its ten-week,...
Feb 6, 2004 | NEWS
February 6, 2004 Gene encoding FLAP also confers risk for stroke; discovery pinpoints common biological mechanism underlying two of the world’s biggest public health challenges In a paper published in the online edition of Nature Genetics, a deCODE-led team of...
Jan 7, 2004 | NEWS
January 7, 2004 Reykjavik, ICELAND, January 7, 2004 — deCODE genetics (Nasdaq:DCGN) and The Simons Foundation, a New York-based organization supporting advanced research in the basic sciences, today announced the launch of the first ever population-based study of the...
Dec 11, 2003 | NEWS
Common forms of these genes confer significant predisposition to obesity Reykjavik, ICELAND, December 11, 2003 — deCODE genetics (Nasdaq:DCGN) today announced that it has isolated two new genes as part of its alliance with Merck & Co, Inc. to develop drugs for...
Nov 19, 2003 | NEWS
Reykjavik, ICELAND, November 17, 2003 — deCODE genetics (Nasdaq:DCGN) today announced that it has acquired an exclusive worldwide license from Bayer AG to develop and commercialize a small molecule compound. The compound is active against a key target, located within...
